Funding Opportunities

PanKbase plans to offer annual pilot funding opportunities to support the timely adoption of rapid advancements in Artificial Intelligence (AI) and data science into the PanKbase platform. Awardees are expected to share all data and AI products generated through the awarded projects via the PanKbase platform and through close collaboration with the PanKbase team. The priority areas of interest will be updated annually. In 2025, two types of applications will be considered:

• Partner Programs: Proposals from programs that are interested in partnering with PanKbase to enhance the interoperability and harmonization between their platforms and PanKbase, by leveraging generative AI, large language models (LLMs), and/or retrieval-augmented generation (RAG).
• Research Teams: Proposals from teams developing foundational models or AI agents of the pancreas with a focus on type 1 diabetes (T1D), as well as AI applications that integrate multimodal data, or enhance the usability, accessibility, or training capabilities of PanKbase.

KEY DATES
Application Due Date:                                  August 31, 2025
Start Date:                                                    November 15, 2025 
Eligibility:                                                      Foreign applications are not eligible

The New Investigator Gateway Award in T1D Research is designed to support a robust pipeline of innovative projects and talented new investigators in T1D research. In addition to providing support for preliminary research, the Gateway program provides an opportunity for new Program Directors/Principal Investigators (PD/PIs) to pursue their studies within the intellectual environment of a select number of large, ongoing collaborative research programs. Embedding awardees within an established scientific framework in each of these consortia will provide unique opportunities for New and Early Stage Investigators to increase their understanding of key questions in the field, to network, and to establish unique and potentially long-lasting collaborations that will propel their careers forward. Bringing New and Early Stage Investigators into existing collaborative research networks will also benefit the networks by providing new ideas and perspectives. 

This NOFO is associated with the Special Diabetes Program which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.  

Application due date:

• March 6, 2026